Actionable news
0
All posts from Actionable news
Actionable news in DEPO: Depomed, Inc.,

Prospectuses and communications, business combinations

BGCOLOR="WHITE">

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 13, 2015

Horizon Pharma Public Limited Company

(Exact name of registrant as specified in its charter)

Connaught House, 1 st Floor, 1 Burlington Road, Dublin 4, D04 C5Y6, Ireland

(Address of principal executive offices)

Registrants telephone number, including area code: 011-353-1-772-2100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Item 5.07 Submission of Matters to a Vote of Security Holders.

On November 13, 2015, in Dublin, Ireland, Horizon Pharma plc (Horizon Pharma) convened an extraordinary general meeting of its shareholders (the Horizon EGM) to vote on the following proposals:

There were 159,279,247 Horizon Pharma ordinary shares outstanding as of the October 7, 2015 record date for the Horizon EGM and a quorum was present for the Horizon EGM. The final voting results for the proposals put forward at the Horizon EGM are as follows:

Proposal 1 Share Issuance Proposal

Accordingly, the share issuance proposal (Proposal No. 1) was approved.

Proposal 2 Authorized Share Capital Increase Proposal

Accordingly, the authorized share capital increase proposal (Proposal No. 2) was approved.

Proposal 3 Directors Allotment Authority Proposal

Accordingly, the directors allotment authority proposal (Proposal No. 3) was approved.

Proposal 4 Pre-Emption Rights Dis-Application Proposal

The pre-emption rights dis-application proposal (Proposal No. 4) required 75 percent approval and it was not approved.

Proposal 5 Adjournment Proposal...


More